USA

3:00 p.m. SESSION 1: Opportunities for larger Bavarian companies to work with the NIH

• Introduction to the NIH as a technology development and commercialization partner

• Value-add to larger companies of working with the NIH

• Case studies of products co-developed with the NIH

• Public market success stories; i.e. examples of blockbuster products brought to market by partnering with, or licensing from, the NIH

• Q&A

When it's time, join the meeting by clicking this link
Meeting number (access code): 735 504 802 ; Meeting password: 3QfMvGT?

4:00 p.m. SESSION 2: Opportunities for Bavarian SMEs to work with the NIH

• Introduction to the NIH as a technology development and commercialization partner

• Value-add to SMEs of working with the NIH – including industry-favorable terms making SMEs attractive to early-stage equity investors

• Case studies of products co-developed with the NIH

• Special licensing opportunities for SMEs

• Q&A

When it's time, join the meeting by clicking this link
Meeting number (access code): 735 504 802 ; Meeting password: 3QfMvGT?

Join from a video system or application dial 735504802@cbiit.webex.com
You can also dial 173.243.2.68 and enter your meeting number.
Join by phone: +49-692-551-14405 Call-in toll number (Germany)
Click “Global call-in numbers” if connecting from other locations.

THE ORGANIZATION
The National Institutes of Health (NIH) is the largest science and medical research institute in the world. NIH’s more than 100 technology transfer professionals help hundreds of researchers – from basic to translational to clinical – patent their discoveries and license them to companies so they progress towards the marketplace.
Long thought of as the go-to place for academics to work with a thought-leader and publish in a top-tier journal, NIH’s technology transfer offices are establishing themselves as open for business – as one of the go-to places for the healthcare industry to work with a thought-leader, overcome a technology or knowledge gap, and get their products to market.
Translational and clinical innovators across 27 Institutes and Centers cover nearly every disease and disorder imaginable – and marketable. We develop drugs – as well as devices, diagnostics, wearable and digital health solutions, and software. We have the largest clinical center in the world – where >1,000 trials run concurrently – provide clinical validation studies of first-in-human medical solutions. Our industry-friendly business terms include no up-front equity for licensees and a highly competitive overhead rate for collaborative projects.

CONTACT:
Michael L. Salgaller, Ph.D.
Supervisor, Invention Development and Marketing Unit (IDMU)
Technology Transfer Center  |  National Cancer Institute  |  National Institutes of Health
michael.salgaller@remove-this.nih.gov; https://techtransfer.cancer.gov

________________________________________

Der German Accelerator Life Sciences unterstützt Start-ups beim Markteintritt in die USA.

Gemeinsam mit Bayern International organisiert Bio^M jedes Jahr einen bayerischen Gemeinschaftsstand auf der BIO International Convention. Veranstaltungen

Die Bayerische Regierung unterhält in den USA zwei Repräsentanzen, die bayerische Unternehmen bei Geschäftsaktivitäten unterstützen. Bayr. Repräsentanz New York / Bayr. Repräsentanz San Francisco

Im Rahmen des eLSi-Projekts hat Bio^M mit den Projektpartnern ein umfangreiches, kostenloses Informationspaket zu Life Science Branche und Geschäftskultur in den USA erstellt.  eLSi USA